---
title: "12 Health Care Stocks Moving In Tuesday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289969175.md"
description: "In Tuesday's after-market session, several healthcare stocks saw significant movement. Lunai Bioworks surged 77.8% to $5.06, while 60 Degrees, MiNK Therapeutics, Processa Pharma, Redhill Biopharma, and SenesTech also posted gains. Conversely, NeOnc Technologies dropped 13.2%, CervoMed fell 11.73%, Neumora Therapeutics declined 10.26%, Aditxt plummeted 10.1%, TELA Bio decreased 9.69%, and Champions Oncology fell 6.25%. Market caps ranged from $3.9 million to $169.4 million."
datetime: "2026-06-16T21:06:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289969175.md)
  - [en](https://longbridge.com/en/news/289969175.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289969175.md)
---

# 12 Health Care Stocks Moving In Tuesday's After-Market Session

### Gainers

-   **Lunai Bioworks** (NASDAQ:LNAI) stock increased by 77.8% to $5.06 during Tuesday's after-market session. The company's market cap stands at $11.8 million.
-   **60 Degrees** (NASDAQ:SXTP) shares increased by 5.47% to $1.54. The market value of their outstanding shares is at $3.9 million.
-   **MiNK Therapeutics** (NASDAQ:INKT) shares moved upwards by 5.27% to $12.43. The company's market cap stands at $62.4 million.
-   **Processa Pharma** (NASDAQ:PCSA) shares increased by 5.26% to $2.2. The company's market cap stands at $6.0 million.
-   **Redhill Biopharma** (NASDAQ:RDHL) shares moved upwards by 5.25% to $0.83. The company's market cap stands at $4.3 million.
-   **SenesTech** (NASDAQ:SNES) stock moved upwards by 4.89% to $1.65. The company's market cap stands at $8.7 million.

### Losers

-   **NeOnc Technologies Hldgs** (NASDAQ:NTHI) stock decreased by 13.2% to $4.49 during Tuesday's after-market session. The company's market cap stands at $117.3 million.
-   **CervoMed** (NASDAQ:CRVO) stock declined by 11.73% to $3.99. The company's market cap stands at $22.9 million.
-   **Neumora Therapeutics** (NASDAQ:NMRA) shares fell 10.26% to $1.4. The market value of their outstanding shares is at $169.4 million.
-   **Aditxt** (NASDAQ:ADTX) stock fell 10.1% to $0.01.
-   **TELA Bio** (NASDAQ:TELA) stock decreased by 9.69% to $0.81. The company's market cap stands at $35.8 million.
-   **Champions Oncology** (NASDAQ:CSBR) stock declined by 6.25% to $6.45. The market value of their outstanding shares is at $88.0 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [NMRA.US](https://longbridge.com/en/quote/NMRA.US.md)
- [ADTX.US](https://longbridge.com/en/quote/ADTX.US.md)
- [PCSA.US](https://longbridge.com/en/quote/PCSA.US.md)
- [TELA.US](https://longbridge.com/en/quote/TELA.US.md)
- [SNES.US](https://longbridge.com/en/quote/SNES.US.md)
- [SXTPW.US](https://longbridge.com/en/quote/SXTPW.US.md)
- [NTHI.US](https://longbridge.com/en/quote/NTHI.US.md)
- [CRVO.US](https://longbridge.com/en/quote/CRVO.US.md)
- [RDHL.US](https://longbridge.com/en/quote/RDHL.US.md)
- [LNAI.US](https://longbridge.com/en/quote/LNAI.US.md)
- [SXTP.US](https://longbridge.com/en/quote/SXTP.US.md)
- [INKT.US](https://longbridge.com/en/quote/INKT.US.md)
- [CSBR.US](https://longbridge.com/en/quote/CSBR.US.md)
- [RENB.US](https://longbridge.com/en/quote/RENB.US.md)

## Related News & Research

- [Cervo posts investor presentation on website covering clinical, development and financial updates](https://longbridge.com/en/news/289829022.md)
- [60 Degrees Pharmaceuticals (NASDAQ:SXTP) CEO Geoffrey Dow Acquires 7,350 Shares](https://longbridge.com/en/news/289892370.md)
- [Penny Stock Neumora Therapeutics Cuts Workforce After Depression Trials Fail](https://longbridge.com/en/news/289813061.md)
- [Aditxt says DRW Securities files initial beneficial ownership statement showing 126,772 shares](https://longbridge.com/en/news/290097214.md)
- [NeOnc says Abu Dhabi health department clears IND for brain cancer drug NEO212](https://longbridge.com/en/news/290059267.md)